Comparison of Casting Materials for the Treatment of Clubfoot Using the Ponseti Method

Sponsor
Alberta Children's Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT01067651
Collaborator
(none)
30
1
2

Study Details

Study Description

Brief Summary

The purpose of this study was to determine the influence of cast material on correction of congenital idiopathic clubfeet using the Ponseti method.

Condition or Disease Intervention/Treatment Phase
  • Device: Plaster of Paris (POP) casting using the Ponseti Method
  • Device: Semi-Rigid Fiberglass softcast using the Ponseti Method
N/A

Detailed Description

Congenital idiopathic clubfoot is the most common congenital deformity in children. It can be a major cause of disability for children, as well as an emotional stress for parents. The Ponseti method of clubfoot correction, consisting of serial manipulations and casting, is now the gold standard of treatment. It has traditionally been described using plaster of Paris (POP) above-knee casts; however, recently semi-rigid fiberglass softcast (SRF, 3M Scotchcast) has grown in popularity. There are currently no randomized controlled trials to prove its efficacy with respect to POP.

Study Design

Study Type:
Interventional
Actual Enrollment :
30 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Comparison of Two Different Cast Materials for the Treatment of Congenital Idiopathic Clubfoot Using the Ponseti Method: A Prospective Randomized Controlled Trial

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Plaster of Paris (POP)

Device: Plaster of Paris (POP) casting using the Ponseti Method

Active Comparator: semi-rigid fiberglass softcast (SRF, 3M Scotchcast)

Device: Semi-Rigid Fiberglass softcast using the Ponseti Method

Outcome Measures

Primary Outcome Measures

  1. number of casts required to correct the clubfoot deformities [time required for the foot to be ready for a percutaneous tendo-achilles tenotomy (if necessary), or when dorsiflexion of the ankle greater than or equal to 15 degrees (Pirani=0) was achieved]

Secondary Outcome Measures

  1. need for percutaneous tendo-achilles tenotomy []

  2. total time in casts (weeks) []

  3. ease of cast removal []

  4. time of cast removal [number of minutes required for each cast removal]

  5. method(s) of cast removal []

  6. other concerns about the casting material (e.g. appearance, weight, cleaning, water resistance), and complications relating to the casting material. []

Eligibility Criteria

Criteria

Ages Eligible for Study:
1 Week to 12 Weeks
Sexes Eligible for Study:
All
Inclusion Criteria:
  • congenital idiopathic clubfoot
Exclusion Criteria:
  • positional equinovarus

  • teratologic etiologies of clubfoot

  • treatment started at another center

  • refuse randomization

  • do not understand English

Contacts and Locations

Locations

Site City State Country Postal Code
1 Alberta Children's Hospital Calgary Alberta Canada T3B 6A8

Sponsors and Collaborators

  • Alberta Children's Hospital

Investigators

  • Principal Investigator: Jason Howard, MD, IWK Health Centre

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT01067651
Other Study ID Numbers:
  • E-20062
First Posted:
Feb 11, 2010
Last Update Posted:
Feb 11, 2010
Last Verified:
Apr 1, 2007
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 11, 2010